ABCL - Abcellera Biologics Inc
This page shows which of the focused investors we track hold ABCL and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2023 it was held by 1 manager with an aggregate reported value of $3.04M, which is 0.00% of the combined portfolio.
As of Q3 2023, 1 tracked institutional manager held ABCL (Abcellera Biologics Inc) with an aggregate reported value of $3.04M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ABCL — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2023
- Ticker
- ABCL
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.11% | - | 659,750 | $3.04M |
Loading holder history for ABCL…